72 related articles for article (PubMed ID: 12771925)
1. Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target.
Tsang TY; Wei W; Itamochi H; Tambouret R; Birrer MJ
Oncotarget; 2017 Nov; 8(57):96482-96495. PubMed ID: 29228547
[TBL] [Abstract][Full Text] [Related]
2. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples.
Penner-Goeke S; Lichtensztejn Z; Neufeld M; Ali JL; Altman AD; Nachtigal MW; McManus KJ
PLoS Genet; 2017 Apr; 13(4):e1006707. PubMed ID: 28376088
[TBL] [Abstract][Full Text] [Related]
3. Cancer genomics: why rare is valuable.
Jamshidi F; Nielsen TO; Huntsman DG
J Mol Med (Berl); 2015 Apr; 93(4):369-81. PubMed ID: 25676695
[TBL] [Abstract][Full Text] [Related]
4. Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.
Yamashita Y; Akatsuka S; Shinjo K; Yatabe Y; Kobayashi H; Seko H; Kajiyama H; Kikkawa F; Takahashi T; Toyokuni S
PLoS One; 2013; 8(3):e57724. PubMed ID: 23469222
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development.
Zhao C; Wu LS; Barner R
J Cancer; 2011 Feb; 2():94-106. PubMed ID: 21479128
[TBL] [Abstract][Full Text] [Related]
6. ARID1A mutations in endometriosis-associated ovarian carcinomas.
Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
[TBL] [Abstract][Full Text] [Related]
7. DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma.
Kuo KT; Mao TL; Chen X; Feng Y; Nakayama K; Wang Y; Glas R; Ma MJ; Kurman RJ; Shih IeM; Wang TL
Clin Cancer Res; 2010 Apr; 16(7):1997-2008. PubMed ID: 20233889
[TBL] [Abstract][Full Text] [Related]
8. An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.
Yamamoto S; Tsuda H; Suzuki K; Takano M; Tamai S; Matsubara O
Virchows Arch; 2009 Sep; 455(3):261-70. PubMed ID: 19655165
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer.
Cho KR; Shih IeM
Annu Rev Pathol; 2009; 4():287-313. PubMed ID: 18842102
[TBL] [Abstract][Full Text] [Related]
10. Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization.
Caserta D; Benkhalifa M; Baldi M; Fiorentino F; Qumsiyeh M; Moscarini M
Mol Cytogenet; 2008 May; 1():10. PubMed ID: 18492273
[TBL] [Abstract][Full Text] [Related]
11. Ovarian clear cell adenocarcinoma: a continuing enigma.
Tan DS; Kaye S
J Clin Pathol; 2007 Apr; 60(4):355-60. PubMed ID: 17018684
[TBL] [Abstract][Full Text] [Related]
12. High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer.
Bernardini M; Lee CH; Beheshti B; Prasad M; Albert M; Marrano P; Begley H; Shaw P; Covens A; Murphy J; Rosen B; Minkin S; Squire JA; Macgregor PF
Neoplasia; 2005 Jun; 7(6):603-13. PubMed ID: 16036111
[TBL] [Abstract][Full Text] [Related]
13. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.
Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT
Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744
[TBL] [Abstract][Full Text] [Related]
14. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types.
Okada S; Tsuda H; Takarabe T; Yoshikawa H; Taketani Y; Hirohashi S
Jpn J Cancer Res; 2002 Jul; 93(7):798-806. PubMed ID: 12149146
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization.
Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H
Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940
[TBL] [Abstract][Full Text] [Related]
17. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation.
Dent J; Hall GD; Wilkinson N; Perren TJ; Richmond I; Markham AF; Murphy H; Bell SM
Br J Cancer; 2003 May; 88(10):1578-83. PubMed ID: 12771925
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
